Omega-3 polyunsaturated fatty acids and cardiovascular diseases.

By C. Lavie, Richard V. Milani, Mandeep R. Mehra, H. Ventura. Journal of the American College of Cardiology, 2009

596 citations recorded by the source corpus.

Subfields: Biochemistry, Nutrition and Dietetics, Surgery

View Paper: https://www.semanticscholar.org/paper/bee4c5ca90fae49f5fc86fefafe88422c084ed61

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Biochemistry

In Nutrition and Dietetics

In Surgery

C. Stanton

Citations in the corpus

2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. (2013, methodology): “The diagnosis of HFpEF is more challenging than the diagnosis of HFrEF because it is largely one of excluding other potential noncardiac causes of symptoms suggestive of HF. Studies have suggested that the incidence of HFpE is increasing and that a greater portion of patients hospitalized with HF ha”
Nanoscience and nanotechnologies in food industries: opportunities and research trends (2014, background): “However, they require both stabilization procedures and protection against deterioration factors since they are highly sensitive to oxidation Lavie et al. (2009), Ruxton et al. (2004) Two systems based on casein (casein nanostructures and reformed casein micelles) showed remarkable protective…”
Marine Bioactives as Functional Food Ingredients: Potential to Reduce the Incidence of Chronic Diseases (2011, background): “Numerous epidemiological and experimental studies have conclusively shown that diets rich in fish and fish oils are associated with a reduced risk of CVD [202–211].”
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2013, methodology): “Supplementation with omega-3 PUFA has been evaluated as an adjunctive therapy for cardiovascular disease and HF (541).”